RT Journal Article
SR Electronic
T1 The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
JF Journal of Neurology, Neurosurgery & Psychiatry
JO J Neurol Neurosurg Psychiatry
FD BMJ Publishing Group Ltd
SP 854
OP 855
DO 10.1136/jnnp.46.9.854
VO 46
IS 9
A1 P Hilton
A1 K Hertogs
A1 S L Stanton
YR 1983
UL http://jnnp.bmj.com/content/46/9/854.abstract
AB Sixteen women with multiple sclerosis who complained of nocturia completed a double-blind cross-over trial of Desmopressin (DDAVP) and placebo. Nocturia was reduced from a mean of 2.55 voids to 2.01 with placebo and to 1.28 with Desmopressin (p less than 0.01, for the difference between placebo and Desmopressin). Side effects were minor, and equally distributed between treatment and placebo.